EDS‐FLU efficacy in patients with chronic rhinosinusitis with or without prior sinus surgery in ReOpen1 and ReOpen2 randomized controlled trials
EDS-FLU improved symptoms, sinus opacification, and quality of life in patients with CRS with or without prior ESS, suggesting a role for EDS-FLU in both populations.
Authors
- Greg E. Davis (ORCID: https://orcid.org/0000-0002-5373-5559)
- Anju T. Peters (ORCID: https://orcid.org/0000-0003-0745-2379)
- Rodney J. Schlosser (ORCID: https://orcid.org/0000-0001-6480-0275)
- Ramy Mahmoud (ORCID: https://orcid.org/0000-0003-4456-1865)
- Mahboobeh Mahdavinia (ORCID: https://orcid.org/0000-0003-4004-203X)
- Andrew A. White (ORCID: https://orcid.org/0000-0002-9859-0947)
- Raj Sindwani (ORCID: https://orcid.org/0000-0002-6584-922X)
- John Messina (ORCID: https://orcid.org/0000-0003-0167-2151)
- Zara M. Patel (ORCID: https://orcid.org/0000-0003-2072-982X)
- Zachary M. Soler (ORCID: https://orcid.org/0000-0002-4304-595X)
- Rakesh K. Chandra
- Nithin D. Adappa (ORCID: https://orcid.org/0000-0002-0339-8769)
- Sarah K. Wise (ORCID: https://orcid.org/0000-0002-6398-0056)
- James Palmer
Institutions
- Northwestern University (US)
- Cleveland Clinic (US)
- Emory University (US)
- Medical University of South Carolina (US)
- University of Washington (US)
- OptiNose (United States) (US)
- Scripps Clinic (US)
- University of Pennsylvania (US)
- Vanderbilt University Medical Center (US)
- The University of Texas Health Science Center at Houston (US)
- Stanford University (US)
Publication Details
- Journal
- International Forum of Allergy & Rhinology
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1002/alr.23434
- Citations
- 3
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.74